BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 14648808)

  • 1. Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-alpha or -gamma agonists in a type 2 diabetic animal model.
    Kim SK; Zhao ZS; Lee YJ; Lee KE; Kang SM; Choi D; Lim SK; Chung N; Lee HC; Cha BS
    Diabetes Metab Res Rev; 2003; 19(6):487-93. PubMed ID: 14648808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue-specific regulation of malonyl-CoA decarboxylase activity in OLETF rats.
    Kim HJ; Zhao ZS; Lee YJ; Shim WS; Kim SK; Ahn CW; Park CW; Lee HC; Cha BS
    Diabetes Obes Metab; 2006 Mar; 8(2):175-83. PubMed ID: 16448521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
    Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
    Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pravastatin on progression of glucose intolerance and cardiovascular remodeling in a type II diabetes model.
    Yu Y; Ohmori K; Chen Y; Sato C; Kiyomoto H; Shinomiya K; Takeuchi H; Mizushige K; Kohno M
    J Am Coll Cardiol; 2004 Aug; 44(4):904-13. PubMed ID: 15312879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
    Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
    J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The different mechanisms of insulin sensitizers to prevent type 2 diabetes in OLETF rats.
    Choi SH; Zhao ZS; Lee YJ; Kim SK; Kim DJ; Ahn CW; Lim SK; Lee HC; Cha BS
    Diabetes Metab Res Rev; 2007 Jul; 23(5):411-8. PubMed ID: 17538941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factor-kappa-B pathway.
    Ogata T; Miyauchi T; Sakai S; Takanashi M; Irukayama-Tomobe Y; Yamaguchi I
    J Am Coll Cardiol; 2004 Apr; 43(8):1481-8. PubMed ID: 15093887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keishibukuryogan ameliorates glucose intolerance and hyperlipidemia in Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Nakagawa T; Goto H; Hussein G; Hikiami H; Shibahara N; Shimada Y
    Diabetes Res Clin Pract; 2008 Apr; 80(1):40-7. PubMed ID: 18242756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Otsuka Long-Evans Tokushima fatty (OLETF) rat is not a suitable animal model for the study of angiopathic diabetic retinopathy.
    Matsuura T; Yamagishi S; Kodama Y; Shibata R; Ueda S; Narama I
    Int J Tissue React; 2005; 27(2):59-62. PubMed ID: 16035649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor.
    Ihm SH; Chang K; Kim HY; Baek SH; Youn HJ; Seung KB; Kim JH
    Basic Res Cardiol; 2010 May; 105(3):399-407. PubMed ID: 19902320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone but not glibenclamide improves cardiac expression of heat shock protein 72 and tolerance against ischemia/reperfusion injury in the heredity insulin-resistant rat.
    Taniguchi Y; Ooie T; Takahashi N; Shinohara T; Nakagawa M; Yonemochi H; Hara M; Yoshimatsu H; Saikawa T
    Diabetes; 2006 Aug; 55(8):2371-8. PubMed ID: 16873703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of timely insulin administration on pancreatic B-cells of Otsuka-Long-Evans-Tokushima-Fatty (OLETF) strain rats. An animal model of non-insulin dependent diabetes mellitus (NIDDM).
    Ishida K; Mizuno A; Sano T; Noma Y; Shima K
    Horm Metab Res; 1995 Sep; 27(9):398-402. PubMed ID: 8557237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level.
    Lee GY; Kim NH; Zhao ZS; Cha BS; Kim YS
    Biochem J; 2004 Mar; 378(Pt 3):983-90. PubMed ID: 14641110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenocortical insufficiency in Otsuka Long-Evans Tokushima Fatty rats, a type 2 diabetes mellitus model.
    Noguchi S; Ohno Y; Aoki N
    Metabolism; 2007 Oct; 56(10):1326-33. PubMed ID: 17884440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pioglitazone improves left ventricular diastolic function and decreases collagen accumulation in prediabetic stage of a type II diabetic rat.
    Tsuji T; Mizushige K; Noma T; Murakami K; Ohmori K; Miyatake A; Kohno M
    J Cardiovasc Pharmacol; 2001 Dec; 38(6):868-74. PubMed ID: 11707690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rare sugar D-psicose improves insulin sensitivity and glucose tolerance in type 2 diabetes Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Hossain MA; Kitagaki S; Nakano D; Nishiyama A; Funamoto Y; Matsunaga T; Tsukamoto I; Yamaguchi F; Kamitori K; Dong Y; Hirata Y; Murao K; Toyoda Y; Tokuda M
    Biochem Biophys Res Commun; 2011 Feb; 405(1):7-12. PubMed ID: 21187061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal renal structural alterations during the development of diabetes mellitus in Otsuka Long-Evans Tokushima Fatty rats.
    Koike T; Tomoda F; Kinuno H; Inoue H; Takata M
    Acta Physiol Scand; 2005 May; 184(1):73-81. PubMed ID: 15847646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms underlying the impaired EDHF-type relaxation response in mesenteric arteries from Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
    Matsumoto T; Kobayashi T; Kamata K
    Eur J Pharmacol; 2006 May; 538(1-3):132-40. PubMed ID: 16678154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of the Chinese prescription Hachimi-jio-gan against renal damage in the Otsuka Long-Evans Tokushima fatty rat: a model of human type 2 diabetes mellitus.
    Yamabe N; Yokozawa T
    J Pharm Pharmacol; 2006 Apr; 58(4):535-45. PubMed ID: 16597372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.